August 2026
Deepa Pandey a Healthcare Industry Expert, highlights that the bioanalytical testing services market has reached USD USD 6.23 billion in 2026 and is on track to reach USD 13.59 billion by 2035, advancing at a CAGR of 9.08%. Key bioanalytical testing services market companies shaping the market include PPD, Inc., ICON Plc, Charles River Laboratories International, Covance, Inc. while major growth segments By Test Type, By Molecules, By Application, By End User, By Region.
September 2026
The preclinical bioanalytical testing services market was valued at USD 1.18 billion in 2025 and is expected to expand at a CAGR of 10.80% from 2026 to 2035. Research by Deepa Pandey, Senior Research Analyst.
September 2026
The global cell and gene therapy bioanalytical testing services market size is expected to hit around USD 1,113.86 million by 2034 from USD 632.03 million in 2026, with a CAGR of 7.34%.